New Resource for Drug Developers: The Rare Disease Repurposing Database (RDRD)
The FDA's Office of Orphan Products Development (OOPD) has established a new resource for drug developers - a database of products that have received orphan status designation and are already market-approved for the treatment of some other diseases. Read more...
